Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies

Diagnosing and Treating Hyperlipidemia: Recent Evidence and the Role of PCSK9-targeted Therapies

Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVDПодробнее

Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C in Hyperlipidemia and ASCVD

PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in HyperlipidemiaПодробнее

PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in Hyperlipidemia

The Role of PCSK9 Inhibitors for Patients with HyperlipidemiaПодробнее

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action)Подробнее

What is PCSK9 and how PCSK9 inhibitors work? (Mechanism of action)

New Guidelines in DyslipidemiaПодробнее

New Guidelines in Dyslipidemia

PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16Подробнее

PCSK9 Inhibitors within the Targeted Treatment Approach to Hypercholesterolemia 4/26/16

The Role of PCSK9 Inhibitors for Patients With HyperlipidemiaПодробнее

The Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular RisksПодробнее

Leveraging PCSK9-Targeting Therapies in Hyperlipidemia Management to Reduce Cardiovascular Risks

Management of Hyperlipidemia: 2018 ACC/AHA Guideline UpdateПодробнее

Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update

Straight From the Experts: Modernizing Hyperlipidemia Management With PCSK9-Targeting AgentsПодробнее

Straight From the Experts: Modernizing Hyperlipidemia Management With PCSK9-Targeting Agents

Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research ConferenceПодробнее

Intertwined Roles of PCSK9 in Lipoprotein Metabolism and Inflammation - Weekly Research Conference

Updates in Guidelines for Chronic Conditions: Diagnosis, Management & Treatment of DyslipidemiaПодробнее

Updates in Guidelines for Chronic Conditions: Diagnosis, Management & Treatment of Dyslipidemia

PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular EventsПодробнее

PCSK9 Inhibition: Lowering Lipids and Reducing Cardiovascular Events

Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted TherapiesПодробнее

Lipid Management Beyond Statins: Timely Intensification With PCSK9-Targeted Therapies

The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)Подробнее

The Cholesterol Wars: Identifying Patients Who Would Most Benefit from PCSK9 Inhibitors (Part 1)

Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant High-Risk ASCVD PatientsПодробнее

Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant High-Risk ASCVD Patients

Pushing the Envelope with PCSK9-Twenty Years of ProgressПодробнее

Pushing the Envelope with PCSK9-Twenty Years of Progress

Familial Hypercholesterolemia - AdventHealth Cardiovascular Grand Rounds - September 2019Подробнее

Familial Hypercholesterolemia - AdventHealth Cardiovascular Grand Rounds - September 2019

Webinar | Lipids in the limelight: clinical update on screening and management | Heart FoundationПодробнее

Webinar | Lipids in the limelight: clinical update on screening and management | Heart Foundation